Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzheng Tongfu Jiedu for Sepsis-Induced Gastrointestinal Dysfunction
NCT06933238Phase 2Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fuzheng Tongfu Jiedu in Digestive tract dysfunction, sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
Fuzheng Tongfu Jiedu
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on NCT06933238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06933238.